Search

Your search keyword '"Herpesvirus 3, Human pathogenicity"' showing total 2 results
Start Over Descriptor "Herpesvirus 3, Human pathogenicity" Region japan
2 results on '"Herpesvirus 3, Human pathogenicity"'

1. [Epidemiology of VZV infection].

Author

Suga S

Subjects
Age Factors, Chickenpox Vaccine, Disease Outbreaks, Herpes Zoster prevention & control, Herpes Zoster virology, Herpesvirus 3, Human pathogenicity, Herpesvirus 3, Human physiology, Humans, Japan epidemiology, Seasons, Sex Factors, Time Factors, United States epidemiology, Virus Replication, Herpes Zoster epidemiology
Published
2006

2. Varicella vaccine.

Author

Chartrand SA

Subjects
Adolescent, Adult, Animals, Asian People, Chickenpox complications, Chickenpox immunology, Child, Herpesvirus 3, Human immunology, Herpesvirus 3, Human pathogenicity, Humans, Immunologic Memory, Japan, Chickenpox Vaccine adverse effects, Chickenpox Vaccine classification, Chickenpox Vaccine immunology
Abstract

Varicella vaccine is safe, effective, and cost-effective in healthy children, adolescents, and adults. Breakthrough cases of MVLS are significantly milder than wild-type varicella infection. No severe adverse events have been reported following vaccination, and the incidence of herpes zoster is less in vaccinees than in individuals who have had natural varicella infections. To date, there is no evidence waning immunity following vaccination. "New and improved" varicella vaccines that may be more effective than the current vaccine and can be stored at refrigerator temperatures may soon become available in the United States.

Published
2000
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results